Ariad Pharmaceuticals Inc

CIK 884731 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ariad Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Oct 15, 202140001395064-21-000203
Oct 15, 202130001395064-21-000201
Apr 7, 2017SC 13G/A0001085146-17-000907
Feb 27, 201715-12B0001193125-17-057984
Feb 27, 2017CT ORDER9999999997-17-001121
Feb 21, 2017SC 13D/A0000899140-17-000284
Feb 16, 2017S-8 POS0001193125-17-046777
Feb 16, 20178-K0001193125-17-046700
Feb 16, 2017S-8 POS0001193125-17-046758
Feb 16, 201740000884731-17-000047
Feb 16, 2017S-8 POS0001193125-17-046782
Feb 16, 2017S-8 POS0001193125-17-046793
Feb 16, 201740000884731-17-000050
Feb 16, 2017SC TO-T/A0001193125-17-045992
Feb 16, 201740000884731-17-000057
Feb 16, 2017S-8 POS0001193125-17-046763
Feb 16, 2017S-8 POS0001193125-17-046773
Feb 16, 201740000884731-17-000056
Feb 16, 201740000884731-17-000058
Feb 16, 201740000884731-17-000060
Feb 16, 201725-NSE0001354457-17-000033
Feb 16, 2017S-8 POS0001193125-17-046756
Feb 16, 201740000884731-17-000052
Feb 16, 2017S-8 POS0001193125-17-046797
Feb 16, 201740000884731-17-000049